Table 1.
Demographics and the clinical data of study population.
| Demographic data | |
| Number of volunteers | 40 |
| Age* | 38 (29–54) |
| Male sex | 23 (58%) |
| Number of patients | 40 |
| Age* | 67 (62–73) |
| Male sex | 28 (70%) |
| Primary focus of systemic inflammation | |
| Gastrointestinal tract | 21 (53%) |
| Lung | 11 (27%) |
| Genitourinary tract | 2 (5%) |
| SIRS | 6 (15%) |
| Infection and inflammation parameters | |
| CRP (mg/L)* | 189 (111–263) |
| PCT (ng/mL)* | 2.7 (0.9–5.9) |
| WBC (nL−1)* | 14 (7.4–24) |
| Outcome | |
| Survivor 28 days | 31 (78%) |
| Disease severity scoring | |
| SAPS* | 62 (44–80) |
| SOFA* | 11 (6.3–14) |
| APACHE II* | 25 (17–35) |
SIRS: systemic inflammatory response syndrome, CRP: C-reactive protein, PCT: procalcitonin, WBCC: white blood cell count, SAPS: simplified acute physiology score, SOFA: the sequential organ failure assessment score, APACHE II: acute physiology and chronic health evaluation II, *median with interquartile range.